Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphopenia × Thymalfasin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Stomach Neoplasms 1 MCRC 1 Lymphopenia 1 Hematologic Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Thymalfasin 1 SARS-CoV-2 inactivated vaccines 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06584006 2024-09-19

Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors

The First Affiliated Hospital of Xiamen University

Phase 2 Recruiting

Other hematologic neoplasm

Lymphopenia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡